Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP, OTC:OCTHF), the biotech firm specialising in the development of prescription cannabinoid medicines, said the 128 million shares issued as part of its £640,000 subscription offer of stock will be admitted to trading on February 20.
Advertisement Go to Proactive UK Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Advertisement Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Advertisement Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com